CCM
EXAS

Cinctive Capital Management’s Exact Sciences EXAS Stock Holding History

Cinctive Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50,000
Closed -$3.5M – 545
2022
Q1 		$3.5M Buy
+50,000
New +$3.65M 0.13% 249

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Cinctive Capital Management's EXAS Position: Q1 2026 in Review

Cinctive Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 330,000 shares — an estimated $33.5M sold.

Cinctive Capital Management first reported a position in EXAS in Q3 2020 and held it in 10 quarters. The position peaked at $33.5M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Cinctive Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 330,000 Exact Sciences shares in Q1 2026, an estimated $33.5M.
  • Cinctive Capital Management first reported a position in Exact Sciences in Q3 2020 and held it in 10 quarters.
  • Cinctive Capital Management's Exact Sciences position peaked at $33.5M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.